by Eagle Analytical | May 21, 2020 | Blog, covid19, Eagle Updates, Links
FDA Updates Guidance On Adverse Reporting During a Pandemic The FDA made an update to their final guidance, “Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic”. The guidance document now includes...
by Eagle Analytical | May 15, 2020 | Blog, covid19, Eagle TV, Eagle Updates
COVID-19: Is There Another Possible Spike? Where Did It Originate From? Do you know where the coronavirus came from? Is there really another spike in the coronavirus coming? When’s the vaccine expected to be ready? Dr. David Hussong touches on these topics in...
by Eagle Analytical | May 15, 2020 | Blog, covid19, Eagle Updates, Links
FDA Announces Update on MOU for Compounding Pharmacies On May 13, a standard memorandum of understanding, also known as a MOU, between the FDA and the states was made available for public viewing as part of the regulatory process. The article states that this marks a...
by Eagle Analytical | May 14, 2020 | Blog, covid19, Eagle Updates, Links
FDA Updates Temporary Policy Regarding PPE for Compounders The FDA has issued an update to its Temporary Policy Regarding Non-Standard PPE Practices for Pharmacy Compounders During the COVID-19 Pandemic. In the update, the FDA has clarified that drugs can be...
by Eagle Analytical | May 11, 2020 | Blog, covid19, Eagle Updates, Links
Morphine Sulfate & Epinephrine added to COVID-19 Compounding List FDA has updated two guidance documents that describe temporary policies for the compounding of certain human drugs during the COVID-19 public health emergency. The updates add morphine sulfate and...
by Eagle Analytical | May 4, 2020 | Eagle Updates
Must Read: Cleaning and Disinfection During COVID-19 The CDC has published a detailed document as well as an infographic outlining effective cleaning and disinfection methods. The document subtitled “Interim Recommendations for U.S. Households with Suspected or...
